04:09 PM EDT, 09/10/2025 (MT Newswires) -- Timothy Eugene Sullivan, Chief Financial Officer, on September 08, 2025, sold 42,729 shares in Apellis Pharmaceuticals ( APLS ) for $1,190,130. Following the Form 4 filing with the SEC, Sullivan has control over a total of 171,332 common shares of the company, with 110,936 shares held directly and 60,396 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1492422/000112760225021248/xslF345X05/form4.xml